Quantitative proteomic analysis to determine differentially expressed proteins in axenic amastigotes of Leishmania tropica and Leishmania major.
L. major
L. tropica
Leishmaniasis
amastigote-like
quantitative proteomics
Journal
IUBMB life
ISSN: 1521-6551
Titre abrégé: IUBMB Life
Pays: England
ID NLM: 100888706
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
14
11
2019
revised:
25
03
2020
accepted:
17
04
2020
pubmed:
1
5
2020
medline:
24
11
2021
entrez:
1
5
2020
Statut:
ppublish
Résumé
Cutaneous leishmaniasis is commonly caused by Leishmania major and Leishmania tropica. In the present study, the differential expression of proteins was identified in the amastigote-like forms of L. tropica and L. major in Iranian isolates. Initially, the samples were cultured and identified using PCR-RFLP technique. The Leishmania isolates were then grown in host-free (axenic) culture and prepared to amastigote-like forms, followed by the extraction of their proteins. To identify significant differentially expressed proteins (DEPs) of two types of Leishmania, the label-free quantitative proteomic technique was used based on sequential window acquisition of all theoretical fragment ion spectra mass spectrometry. A total of 51 up/down-DEPs (fold change >2 and p-value <.05) were identified between the axenic amastigote forms of L. major and L. tropica. Of these, 34 and 17 proteins were up-regulated in L. major and L. tropica, respectively. Several enriched GO terms were identified via biological process analyses for DEPs; furthermore, the metabolic process and translation were disclosed as top category in the up-regulated proteins of both L. major and L. tropica species. Also, the KEGG analysis revealed carbon metabolism and metabolic pathways term as the top pathways in the proteins up-regulated in L. major and L. tropica, respectively. Taken together, the numerous novel DEPs identified between the studied species could help fully understand the molecular mechanisms of pathogenesis and provide potential drug targets and vaccine candidates.
Substances chimiques
Protozoan Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1715-1724Informations de copyright
© 2020 International Union of Biochemistry and Molecular Biology.
Références
Ahmadi N, Modiri M, Mamdohi S. First survey of cutaneous leishmaniasis in Borujerd county, western Islamic Republic of Iran. East Mediterr Health J. 2013;19:847-853.
Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS one. 2010;7:e35671.
Ashrafmansouri M, Sarkari B, Hatam G, Habibi P, Khabisi SA. Utility of western blot analysis for the diagnosis of cutaneous leishmaniasis. Iran J Parasitol. 2015;10:599-604.
Habibi P, Sadjjadi S, Owji M, Moattari A, Sarkari B, Naghibalhosseini F. Characterization of in vitro cultivated amastigote like of Leishmania major: A substitution for in vivo studies. Iran J Parasitol. 2008;3:6-15.
Atan NAD, Koushki M, Ahmadi NA, Rezaei-Tavirani M. Metabolomics-based studies in the field of Leishmania/leishmaniasis. Alexandria J Med. 2018;54:383-390.
Leifso K, Cohen-Freue G, Dogra N, Murray A, McMaster WR. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: The Leishmania genome is constitutively expressed. Mol Biochem Parasitol. 2007;152:35-46.
Peacock CS, Seeger K, Harris D, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet. 2007;39:839-847.
Amiri-Dashatan N, Rezaei-Tavirani M, Ahmadi N. A quantitative proteomic and bioinformatics analysis of proteins in metacyclogenesis of Leishmania tropica. Acta Trop. 2019;202:105227.
Amiri-Dashatan N, Koushki M, Rezaei Tavirani M, Ahmadi N. Proteomic-based studies on Leishmania. J Mazandaran Univ Med Sci. 2018;28:173-190.
Gahlaut A, Dahiya M, Gothwal A, et al. Proteomics & metabolomics: Mapping biochemical regulations. Drug Invent Today. 2013;5:321-326.
Megger DA, Bracht T, Meyer HE, Sitek B. Label-free quantification in clinical proteomics. Biochim Biophys Acta. 1834;2013:1581-1590.
Huang Q, Yang L, Luo J, et al. SWATH enables precise label-free quantification on proteome scale. Proteomics. 2015;15:1215-1223.
Tabrizi F, Seyyed Tabaei S, Ahmadi N, Arefi OA. A nuclear magnetic resonance- based metabolomic study to identify metabolites differences between Iranian isolates of Leishmania major and Leishmania tropica. Iran J Med Sci. 2020;46: (in press).
Bente M, Harder S, Wiesgigl M, et al. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics. 2003;3:1811-1829.
Nugent PG, Karsani SA, Wait R, Tempero J, Smith DF. Proteomic analysis of Leishmania mexicana differentiation. Mol Biochem Parasitol. 2004;136:51-62.
McNicoll F, Drummelsmith J, Müller M, et al. A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics. 2006;6:3567-3581.
Moreira DS, Murta SM. Involvement of nucleoside diphosphate kinase b and elongation factor 2 in Leishmania braziliensis antimony resistance phenotype. Parasite Vector. 2016;9:1-12.
Walker J, Gongora R, Vasquez JJ, et al. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol Biochem Parasitol. 2012;183:166-176.
Kaul G, Pattan G, Rafeequi T. Eukaryotic elongation factor-2 (eEF2): Its regulation and peptide chain elongation. Cell Biochem Funct. 2011;29:227-234.
Biyani N, Madhubala R. Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival. Biochim Biophys Acta. 1824;2012:1342-1350.
Boitz JM, Jardim A, Ullman B. GMP reductase and genetic uncoupling of adenylate and guanylate metabolism in Leishmania donovani parasites. Mol Biochem Parasitol. 2016;208:74-83.
Mojtahedi Z, Clos J, Kamali-Sarvestani E. Leishmania major: Identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Experiment Parasitol. 2008;119:422-429.
Lopez C, Chevalier N, Hannaert V, et al. Leishmania donovani phosphofructokinase. Gene characterization, biochemical properties and structure-modeling studies. Eur J Biochem. 2002;269:3978-3989.
Oliveira MP, Martins VT, Santos TT, et al. Small Myristoylated Protein-3, identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral Leishmaniasis. Int J Mol Sci. 2018;19:1-18.
Singh R, Purkait B, Abhishek K, et al. Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b. Cell Biosci. 2016;6:1-17.
Walker J, Vasquez JJ, Gomez MA, et al. Identification of developmentally-regulated proteins in Leishmania panamensis by proteome profiling of promastigotes and axenic amastigotes. Mol Biochem Parasitol. 2006;147:64-73.
Suman SS, Amit A, Singh KP, et al. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis. Cytokine. 2018;108:1-8.
Suman SS, Equbal A, Zaidi A, et al. Up-regulation of cytosolic tryparedoxin in amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase. Biochimie. 2016;121:312-325.
Amiri-Dashatan N, Koushki M, Ahmadi N. Comparison of gene expression of pyruvate kinase and tryparedoxin peroxidase in metacyclic promastigote forms of Leishmania (L.) tropica and L. major by real-time PCR. Ann Parasitol. 2020;66:13-18.
Daifalla NS, Bayih AG, Gedamu L. Differential immune response against recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 proteins in BALB/c mice. J Immunol Res. 2015;2015:348401.
Bhattacharyya SN, Adhya S. tRNA-triggered ATP hydrolysis and generation of membrane potential by the leishmania mitochondrial tRNA import complex. J Biol Chem. 2004;279:11259-11263.
Moore LL, Santrich C, LeBowitz JH. Stage-specific expression of the Leishmania mexicana paraflagellar rod protein PFR-2. Mol Biochem Parasitol. 1996;80:125-135.
Portman N, Gull K. The paraflagellar rod of kinetoplastid parasites: From structure to components and function. Int J Parasitol. 2010;40:135-148.